Results

Total Results: 1,643 records

Showing results for "factor".

101. Disparities-Quality-Improvement Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
     August 01, 2012 - One study of cardiovascular risk factor modification showed no meaningful reduction in health disparities … Cardiovascular Disease Studies of CAD risk factor control included men with CAD risk factors at clinical … The interventions for CAD risk factor control included intensive patient education and self-management … For studies of cardiovascular risk factor control, outcomes consisted of intermediate clinical variables … Responses of black and white males to the special intervention program of the Multiple Risk Factor

102. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
     May 15, 2017 - Rates of RA development are increased in monozygotic twins, implicating genetics as a contributing factor … disease activity remains moderate or high, double or triple combination DMARDs or a tumor necrosis factor … Food and Drug Administration; RA = rheumatoid arthritis; TNF = tumor necrosis factor; ts = targeted … disease-modifying antirheumatic drug; KQ = Key Question; RA = rheumatoid arthritis; TNF = tumor necrosis factor … rheumatoid arthritis; RCT = randomized controlled trial; SR = systematic review; TNF = tumor necrosis factor

103. S66 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
     October 01, 2007 - These drugs include tumor necrosis factor antagonists (anti- TNF) and an interleukin-1 antagonist (anti-IL … Anti-Tumor Ne- crosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. … Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of … Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha … Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006;355:704–712. 42.

104. Cancer-Pancreas Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
     August 09, 2013 - or tumor characteristic Another test: Effect of patient factor or tumor characteristic Staging … FNA • Sedation-related effects of EUS-FNA (e.g., nausea, vomiting) 3a P1 or P2 or P3 Patient factor … Comparator patient factor See the list of harms for KQ 3 3b P1 or P2 or P3 Same list as KQ 1a … Source: www.effectivehealthcare.ahrq.gov Published online: August 9, 2013 9 An important factor … Although this factor will not be addressed formally in the review as a KQ, we plan to collect and provide

105. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
     June 01, 2011 - Another factor that should be considered is the likelihood that relevant information may be imperfectly … In other cases, a factor is considered, but without much rigorous analysis. … VOI in Millions ICER-Trial £11 ICER-Trial ICER-Trial ICER-Trial $46 $308,000 £1 $64 Applied scale factor … for population at risk* - 5.01 - - - 1.00 1.00 5.01 5.01 Applied scale factor for time horizon … for population at risk* 1.0 - - - 13975§ 1 19 19 - Applied scale factor for time horizon 1 - - -

106. S81 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
     October 01, 2007 - Female sex is an independent risk factor for bleeding on anticoagulation.24 Codes for complications and … The model would overestimate the true ADE rate by a factor of 8, but the crude rate of predicted ADEs … A very low PPV would require a high discount factor of nearly 97% to estimate the rate of drug-induced … This high discount factor and the lack of clinically specific markers for delirium decrease the likelihood

107. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
     September 08, 2011 - would be a trial in which randomized assignment to treatment groups would be stratified by predictive factor … level or patients were randomized to receive treatment guided by predictive factor or not. … adequately powered stratified randomization would allow valid inferences of treatment by predictive factor … of two treatments, whereas single-arm studies can only assess the association between predictive factor

108. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
     November 26, 2024 - Quality In Prognosis Studies (QUIPS) tool13 which covers study participation, attrition, prognostic factor … Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework

109. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
     July 01, 2016 - although use of these medications was not routine until the 1990s.4 The first biologic tumor necrosis factor … Stelara)† 0 1 TNF = tumor necrosis factor. † Stakeholder provided comparison. … 0 Other: TNF-alpha inhibitor versus new treatment (that is safer)† 0 1 TNF = tumor necrosis factor … Stelara)† 0 1 TNF: Tumor necrosis factor. † Stakeholder provided comparison. … 0 Other: TNF-alpha inhibitor versus new treatment (that is safer)† 0 1 TNF = tumor necrosis factor

110. Rh Incompatibility | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/rh-incompatibility

111. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
     October 01, 2011 - Subclinical thyroid dysfunction has been shown to be a risk factor for the later development of overt … In addition, a high TSH level may be a risk factor for coronary events, elevated cholesterol levels, … and increased rates of congestive heart failure, while a low TSH level is a risk factor for atrial fibrillation

112. Methods Guide for Medical Test Reviews Chapter 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
     July 01, 2012 - 200217 FDG = fluorodeoxyglucose; FFDM = full-field digital mammography; HER2 = human epidermal growth factor … Technology Evaluation Center, 2002.14 The second example concerns use of the human epidermal growth factor … amplification assay to select patients for HER2-targeted therapy* HER2 = human epidermal growth factor

113. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-extraction.ppt
     January 01, 2009 - Study types include randomized trial, observational study, diagnostic test study, prognostic factor study … extracted, which may be a randomized trial, an observational study, a diagnostic test study, a prognostic factor … will be more objective (especially in their quality assessment) if they are undistracted by the impact factor

114. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - tyrosine kinase inhibitor that targets the intracellular signaling of multiple proangiogenic growth factor … receptor 2 (VEGFR2), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor … Esbriet®) is a synthetic pyridone analogue reported to inhibit the synthesis of transforming growth factor … receptor kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), fibroblast growth … factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR).

115. Zikmund (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/zikmund.pdf
     May 29, 2025 - • Enters risk factor info: o BP, weight, height, cholesterol, etc.

116. Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
     June 01, 2020 - studies may report associations with participant characteristics, e.g., reporting correlations with a factor … AND (“inequit*” OR “disparit*” OR “inequal*”)) OR ((“social*” OR “sociolog*” OR “sociology*”) AND (“factor … disparity OR disparities OR inequality OR inequalities)) OR ((social OR sociological OR sociology) AND (factor

117. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - I believe that older age at first birth should be added as a risk factor for breast cancer. … rating was downgraded because some women in the trial continued to use estrogen--an important risk factor … Age is an important factor in considering this risk benefit ratio. 2. … Factor 5 Leiden. It is not clear why it was marked as "wrong population." 2. … There's not much literature available on this but it might be mentioned, as a limiting factor of the

118. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - program, we have reported clinical outcomes for specific symptom subtypes represented by standard factor … compared to the sham TMS treatment group at both the week 4 and week 6 outcome time points on the Factor … Factor Score, and the Psychomotor Retardation Factor Score. … There was no difference on the Sleep Factor Score, indicating that TMS does not exert a soporific effect … Symptom subtypes represented by standard factor scores measured Berman, (2000) This study in included

119. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Additionally, corticosteroids and tumor necrosis factor (TNF)-alpha inhibitors may also be prescribed … Elevated serum uric acid (sUA) levels are thought to be the most important risk factor for developing … and Allopurinol-Refractory Gout  Key Facts: Hyperuricemia is believed to be the most important risk factor … Allopurinol-Refractory Gout Unmet need: Hyperuricemia is thought to be the most important risk factor … not respond adequately to NSAIDs, disease- modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor

120. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
     March 11, 2010 - Executive summary The term “rate” implies a time factor. What is it? … We are aware that “rate” implies a time factor in epidemiological literature, but the literature on … to raise in this section is that a history of previous benign breast biopsy is a significant risk factor … Prevention paper, Ashbeck et al. demonstrate that a history of previous benign breast biopsy is not a risk factor